Stock Chart

NAUT

$2.01 +3.08%
Score: 51.4 HOLD
LEAPs: SELL $3
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $3
Premium: $0.65
Expiry: Jun 18, 2026
Target: $3
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $1.8 - $2.39 STRONG_UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.77
Vol: 0.47x (vs SPY: 0.5x | vs QQQ: 0.5x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About NAUT - Nautilus Biotechnolgy, Inc. Common Stock

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Key Statistics

Market Cap $246M

This NAUT stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track NAUT's price movements with trendlines, gamma walls, and key support/resistance levels.